Brussels – Ovizio Imaging Systems, a life science imaging technology company,

announces the appointment of Emilie Viey as CEO and board member. Dr. Viey will lead Ovizio’s

further development as solution provider for imaging applications in Life Sciences.

Emilie Viey joins Ovizio Imaging Systems from ACEA Biosciences, a Cell Analysis instruments

company based in San Diego (USA), where she was Director of Commercialization and set up the

complete organization for Europe. Before that, she was application scientist at Roche Diagnostics

France for Cellular Analysis Instruments (Cell Counters, Imaging Platform and Label Free Cell

Analyzers). Emilie holds a MSc. in Biochemistry and a PhD in Immunology.

Philip Mathuis, co-founder of Ovizio, who is stepping down as CEO, played a crucial role setting up

the company and establishing its operations. He secured funding, developed a portfolio of products

and recruited an outstanding team to move the organization to the next phase.

“Ovizio has a unique technology platform and product portfolio for automated label-free imaging of

cells that offer the capability to fingerprint cells for a large number of applications”, says Dr. Viey. “I

am convinced of the tremendous value Ovizio can bring to the manufacturing of as well traditional

cellular bioprocessing as to the most advanced cell therapy processes. I very much look forward to

working with Ovizio’s team to further expand the company’s reach.”

“Establishing and building Ovizio has been an exciting and extraordinary experience. I’m glad I can

hand over the reins to Emilie who brings deep scientific knowledge, understanding and experience in

cell based instrumentation, from marketing to sales,” explains Philip Mathuis.

Ovizio is an innovative Belgian company developing efficient quantitative microscopy solutions for

life sciences applications. Ovizio’s microscopes offer easy-to-use, label-free and non-invasive tools

for real-time 3D and 4D imaging of living cells. Validated with almost every type of transparent cell

culture vessel, Ovizio’s devices can track cell count, cell morphology and cell viability with the

highest reproducibility at a single cell level. Applicable from R&D to manufacturing processes and

enabling significant cost reductions and quality improvement, Ovizio’s microscopes are particularly

convenient and robust for automated cell culture monitoring, analysis and quality control